<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id><journal-id journal-id-type="publisher-id">BPH</journal-id><journal-title-group><journal-title>British Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0007-1188</issn><issn pub-type="epub">1476-5381</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7323156</article-id><article-id pub-id-type="doi">10.1111/bph.15164</article-id><article-id pub-id-type="publisher-id">BPH15164</article-id><article-id pub-id-type="other">2020-BJP-0688-MR.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Mini&#x02010;review Themed Issue</subject></subj-group><subj-group subj-group-type="heading"><subject>The Pharmacology of Covid&#x02010;19</subject></subj-group></article-categories><title-group><article-title>Harnessing resolving&#x02010;based therapeutics to treat pulmonary viral infections: What can the future offer to COVID&#x02010;19?</article-title><alt-title alt-title-type="left-running-head">Sousa et al.</alt-title></title-group><contrib-group><contrib id="bph15164-cr-0001" contrib-type="author"><name><surname>Sousa</surname><given-names>Lirl&#x000e2;ndia P.</given-names></name><xref ref-type="aff" rid="bph15164-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bph15164-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bph15164-cr-0002" contrib-type="author"><name><surname>Pinho</surname><given-names>Vanessa</given-names></name><xref ref-type="aff" rid="bph15164-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bph15164-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="bph15164-cr-0003" contrib-type="author" corresp="yes"><name><surname>Teixeira</surname><given-names>Mauro M.</given-names></name><xref ref-type="aff" rid="bph15164-aff-0001">
<sup>1</sup>
</xref><address><email>mmtex@icb.ufmg.br</email></address></contrib></contrib-group><aff id="bph15164-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Laboratorio de Imunofamacologia, Departamento de Bioqu&#x000ed;mica e Imunologia, Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas</named-content>
<institution>Universidade Federal de Minas Gerais</institution>
<city>Belo Horizonte</city>
<country country="BR">Brazil</country>
</aff><aff id="bph15164-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Departamento de An&#x000e1;lises Cl&#x000ed;nicas e Toxicol&#x000f3;gicas, Faculdade de Farm&#x000e1;cia</named-content>
<institution>Universidade Federal de Minas Gerais</institution>
<city>Belo Horizonte</city>
<country country="BR">Brazil</country>
</aff><aff id="bph15164-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Departamento de Morfologia, Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas</named-content>
<institution>Universidade Federal de Minas Gerais</institution>
<city>Belo Horizonte</city>
<country country="BR">Brazil</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Mauro Martins Teixeira &#x02010; Departamento de Bioqu&#x000ed;mica e Imunologia, Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas, Universidade Federal de Minas Gerais. Av. Ant&#x000f4;nio Carlos, 6627 &#x02013; Pampulha &#x02010; 31270&#x02010;901 &#x02010; Belo Horizonte, MG, Brasil.<break/>
Phone # 55 31 3409 2651<break/>
Email: <email>mmtex@icb.ufmg.br</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>6</month><year>2020</year></pub-date><elocation-id>10.1111/bph.15164</elocation-id><history><date date-type="received"><day>14</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>29</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>6</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 The British Pharmacological Society <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:BPH-9999-na.pdf"/><abstract><p>Inflammation is generally believed to be a protective response in the context of infectious diseases. However, altered inflammatory responses can contribute to disease in infected individuals. Multiple mediators that drive the resolution of inflammation have been described. Overall, mediators of resolution tend to decrease inflammatory responses and provide normal or greater ability of the host to deal with infection. In the lung, it seems that pro&#x02010;resolving molecules or strategies that promote their increase tend to decrease inflammation and lung injury and facilitate control of bacterial or viral burden. Here, we argue that the demonstrated anti&#x02010;inflammatory, pro&#x02010;resolving, anti&#x02010;thrombogenic and anti&#x02010;microbial effects of pro&#x02010;resolution mediators may be useful in the treatment of the late stages of disease in patients with COVID&#x02010;19.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="bph15164-kwd-0001">Inflammation</kwd><kwd id="bph15164-kwd-0002">resolution</kwd><kwd id="bph15164-kwd-0003">COVID&#x02010;19</kwd><kwd id="bph15164-kwd-0004">cytokines</kwd><kwd id="bph15164-kwd-0005">thrombosis</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="1"/><word-count count="300"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:29.06.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="bph15164-cit-0001">
<string-name>
<surname>Sousa</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Pinho</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Teixeira</surname>
<given-names>MM</given-names>
</string-name>. <article-title>Harnessing resolving&#x02010;based therapeutics to treat pulmonary viral infections: What can the future offer to COVID&#x02010;19?</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1111/bph.15164</pub-id>
</mixed-citation>
</p><fn-group id="bph15164-ntgp-0001"><fn id="bph15164-note-0001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bph.15164.</p></fn></fn-group></notes></front></article>